Matthias Rath, an advocate of using vitamins and proper nutrition to fight illness, including HIV infection, placed a full-page ad in Tuesday's edition of The New York Times and the International Herald Tribune, an international newspaper headquartered in Paris, calling HIV antiretroviral drugs toxic. In the ad, Rath says micronutrients are "an effective, safe, and affordable" approach to treating HIV disease. Rath, who in the past has accused the United States, the World Bank, and other Western institutions of promoting the use of anti-HIV drugs to boost sales for pharmaceutical companies, says the claims in his ad are supported by a Harvard University study that showed that HIV-positive women in Africa who received a multivitamin with high doses of vitamin E, vitamin C, and vitamin B-complex, as well as other key minerals, remained healthier than women who received a placebo. But Harvard researchers Wafaie Fawzi and David Hunter said in a statement that Rath is "deliberately misinterpreting" their research to support his ongoing campaign against anti-HIV drug use. "We condemn these irresponsible and misleading statements as in our view they deliberately misinterpret findings from our studies to advocate against the scale-up of antiretroviral therapy," the researchers say. "It is important to underscore that the multivitamin supplements should not be considered as an alternative to [antiretroviral therapy] but as a complementary intervention that is part of a comprehensive care package. Antiretroviral therapy saves lives, and its scale-up should be vigorously pursued in all countries." The World Health Organization, the Joint United Nations Programme on HIV/AIDS, and UNICEF also released statements calling Roth's claims misleading and dangerous and reiterating their support for antiretroviral treatment programs around the world.
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Stay up to date with the latest in LGBTQ+ news with The Advocate’s email newsletter, in your inbox five days a week.
@ 2026 Equal Entertainment LLC.
All rights reserved
All rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Latest
Support Independent Journalism
LGBTQ+ stories deserve to betold.
Your membership powers The Advocate's original reporting—stories that inform, protect, and celebrate our community.
Become a Member
FOR AS LITTLE AS $5. CANCEL ANYTIME.
More For You
Most Popular
@ 2026 Equal Entertainment LLC. All Rights reserved















